Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
- 11 June 2004
- journal article
- clinical trial
- Published by Elsevier in Experimental Neurology
- Vol. 188 (2), 491-494
- https://doi.org/10.1016/j.expneurol.2004.05.003
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatments of Parkinson DiseaseArchives of Neurology, 2003
- Effects of Coenzyme Q10 in Early Parkinson DiseaseArchives of Neurology, 2002
- Effect of coenzyme Q 10 and α‐tocopherol content of mitochondria on the production of superoxide anion radicalsThe FASEB Journal, 2000
- Electron Transport-Linked Ubiquinone-Dependent Recycling of α-Tocopherol Inhibits Autooxidation of Mitochondrial MembranesArchives of Biochemistry and Biophysics, 1998
- Oxidation of LDL and their subfractions: Kinetic aspects and CoQ10 contentMolecular Aspects of Medicine, 1997
- Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Interactions between ubiquinones and vitamins in membranes and cellsMolecular Aspects of Medicine, 1994
- Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteersMolecular Aspects of Medicine, 1994
- Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.Proceedings of the National Academy of Sciences, 1991